2024
Suh M, Mittal L, Brorby G , Pastula S, Vincent M, Proctor D. Epidemiology is critical in advancing cumulative impact assessment (CIA) research: A pilot study in San Antonio, Texas. International Society of Exposure Science, Montreal, Canada, October 2024.
View Abstract
Publication: Abstracts and Presentations
East A, Klaren W , Covington T, Rish W. Exploring biomarker-based methods to incorporate non-chemical stressor exposures into cumulative assessments for potentially vulnerable population groups. International Society of Exposure Science, Montreal, Canada, October 2024.
View Abstract
Publication: Abstracts and Presentations
Cook B, Nelms MD, Harris D, Bever RJ, Lynn SC, Borghoff S , et al. Clustering chemicals for predicting behavior and hazards: Insights from the endocrine disruptor screening program (EDSP) universe of chemicals. American Society of Cellular and Computational Toxicology Annual Meeting, Research Triangle Park, NC, October 2024.
View Abstract
Publication: Abstracts and Presentations
Blatt AZ, Suh M , Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Geographic progression of infant respiratory syncytial virus associated bronchiolitis across the United States before and since the onset of COVID-19: Results from four health systems, 2015-2023. Influenza Other Respir Viruses 18(5):e13298; doi: 10.1111/irv.13298 . PMID: 387511.
View Abstract
Publication: Manuscripts
Blatt AZ, Suh M , Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023. Ann Epidemiol 94(June):72–80; doi: 10.1016/j.annepidem.2024.04.010 . PMID: 38685519.
View Abstract
Publication: Manuscripts
Suh M , Movva N, Jiang X, Reichert H, Pastula ST, Sacks NC, Frankenfeld C, Fryzek JP, Simões AF. 2024. Healthcare utilization among infants covered by Medicaid and newly diagnosed with respiratory syncytial virus. Open Forum Infect Dis 11(4)::ofae174; doi: 10.1093/ofid/ofae174 . PMID: 38595954.
View Abstract
Publication: Manuscripts
Vincent M , Fitch S , Bylsma L , Thompson C , Rogers S , Britt J , Wikoff D . Integration of toxicological and epidemiological information to evaluate biological plausibility and causality of associations between inhaled formaldehyde (FA) and lymphohematopoietic (LHP) cancers. Abstract 5157, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.
View Abstract
Publication: Abstracts and Presentations
DeVito M, Bokkers B, van Duursen MBM, van Ede K, Feeley M, Antunes Fernandes Gaspar E, Haws L,… Wheeler M,… Wikoff D , et al. 2024. The 2022 World Health Organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls. Regul Toxicol Pharmacol 146(Jan):105525; doi: 10.1016/j.yrtph.2023.105525 . PMID: 37972849.
View Abstract
Publication: Manuscripts
2023
Ring C, Blanchette A, Klaren WD , Fitch S , Haws L, Wheeler MW, DeVito MJ, Walker N, Wikoff D . 2023. A multi-tiered hierarchical Bayesian approach to derive toxic equivalency factors for dioxin-like compounds. Regul Toxicol Pharmacol 143(11):105464; doi: 10.1016/j.yrtph.2023.105464 . PMID: 37516304.
View Abstract
Publication: Manuscripts
Wikoff D , Ring C, DeVito M, Walker N, Birnbaum L, Haws L. 2023. Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment. Regul Toxicol Pharmacol 145:105500; doi: 10.1016/j.yrtph.2023.105500 . PMID: 37866700.
View Abstract